RB

Robert Bob Brookins

Alexium International Group Limited | Executive Director
Dr Brookins has more than 15 years of experience in organic synthesis and materials chemistry. Dr Brookins led the development and commercialisation of Alexium's phase change material (PCM) platform technologies and the AlexiCool product line, which is the foundation of the Company's success in the bedding and top-of-bed markets. He is a member of the Risk Committee.

Company and Role

Company
Title
Tenure
Since
AJX
AJX
Alexium International Group Limited
  • Executive Director
6yrs, 6mthMay 2018

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
AJX
AJX
Alexium International Group Limited
30/06/2410,696,346N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
AJX
AJX
Alexium International Group Limited
03/05/24
Issued
3,850,000$0.013$50,050Placement
AJX
AJX
Alexium International Group Limited
12/01/24
Issued
6,505,703$0.014$91,079Issue of securities
AJX
AJX
Alexium International Group Limited
31/03/23
Issued
13,377,148$0.020$267,542Issue of securities
AJX
AJX
Alexium International Group Limited
25/10/21
Issued
471,211$0.088$41,466Issue of securities
AJX
AJX
Alexium International Group Limited
08/12/20
Buy
980,400$0.064$62,745Placement